ALDH1A3 is epigenetically regulated during melanocyte transformation and is a target for melanoma treatment
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
ALDH1A3 is epigenetically regulated during melanocyte transformation and is a target for melanoma treatment
Authors
Keywords
-
Journal
ONCOGENE
Volume 36, Issue 41, Pages 5695-5708
Publisher
Springer Nature
Online
2017-06-05
DOI
10.1038/onc.2017.160
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cancer treatment and survivorship statistics, 2016
- (2016) Kimberly D. Miller et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Aldehyde dehydrogenase 1A1 in stem cells and cancer
- (2016) Hiroyuki Tomita et al. Oncotarget
- Aldehyde dehydrogenase as a marker and functional mediator of metastasis in solid tumors
- (2015) Mauricio Rodriguez-Torres et al. CLINICAL & EXPERIMENTAL METASTASIS
- Targeting ALDH1 to decrease tumorigenicity, growth and metastasis of human melanoma
- (2015) Lili Yue et al. MELANOMA RESEARCH
- Cellular Mechanisms of Oxidative Stress and Action in Melanoma
- (2015) Mario Venza et al. Oxidative Medicine and Cellular Longevity
- Aldehyde dehydrogenase 1A3 influences breast cancer progression via differential retinoic acid signaling
- (2014) Paola Marcato et al. Molecular Oncology
- Experience in daily practice with ipilimumab for the treatment of patients with metastatic melanoma: an early increase in lymphocyte and eosinophil counts is associated with improved survival
- (2013) J. Delyon et al. ANNALS OF ONCOLOGY
- The role of aldehyde dehydrogenase (ALDH) in cancer drug resistance
- (2013) Radosław Januchowski et al. BIOMEDICINE & PHARMACOTHERAPY
- ALDH1-Positive Cancer Stem Cells Predict Engraftment of Primary Breast Tumors and Are Governed by a Common Stem Cell Program
- (2013) E. Charafe-Jauffret et al. CANCER RESEARCH
- Cell death and diseases related to oxidative stress:4-hydroxynonenal (HNE) in the balance
- (2013) S Dalleau et al. CELL DEATH AND DIFFERENTIATION
- Aldehyde Dehydrogenase 1A1 Possesses Stem-Like Properties and Predicts Lung Cancer Patient Outcome
- (2012) Xiao Li et al. Journal of Thoracic Oncology
- β-catenin confers resistance to PI3K and AKT inhibitors and subverts FOXO3a to promote metastasis in colon cancer
- (2012) Stephan P Tenbaum et al. NATURE MEDICINE
- Survival in BRAF V600–Mutant Advanced Melanoma Treated with Vemurafenib
- (2012) Jeffrey A. Sosman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Antioxidant Defenses in the ocular surface
- (2012) Ying Chen et al. Ocular Surface
- ALDH1A Isozymes are Markers of Human Melanoma Stem Cells and Potential Therapeutic Targets
- (2012) Yuchun Luo et al. STEM CELLS
- Aldehyde dehydrogenase: Its role as a cancer stem cell marker comes down to the specific isoform
- (2011) Paola Marcato et al. CELL CYCLE
- Slow-Cycling Therapy-Resistant Cancer Cells
- (2011) Nathan Moore et al. STEM CELLS AND DEVELOPMENT
- Methylthioadenosine (MTA) inhibits melanoma cell proliferation and in vivotumor growth
- (2010) Pedro Andreu-Pérez et al. BMC CANCER
- High Aldehyde Dehydrogenase Activity Identifies Tumor-Initiating and Metastasis-Initiating Cells in Human Prostate Cancer
- (2010) Christel van den Hoogen et al. CANCER RESEARCH
- Selection of Tumorigenic Melanoma Cells Using ALDH
- (2010) Jim B. Boonyaratanakornkit et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Prognostic Significance of Tumorigenic Cells With Mesenchymal Features in Pancreatic Adenocarcinoma
- (2010) Zeshaan A. Rasheed et al. JNCI-Journal of the National Cancer Institute
- Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
- (2010) F. Stephen Hodi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Aldehyde Dehydrogenase (ALDH) Activity Does Not Select for Cells with Enhanced Aggressive Properties in Malignant Melanoma
- (2010) Lina Prasmickaite et al. PLoS One
- Quiescent, Slow-Cycling Stem Cell Populations in Cancer: A Review of the Evidence and Discussion of Significance
- (2010) Nathan Moore et al. Journal of Oncology
- Aldehyde Dehydrogenase 1 Is a Marker for Normal and Malignant Human Colonic Stem Cells (SC) and Tracks SC Overpopulation during Colon Tumorigenesis
- (2009) E. H. Huang et al. CANCER RESEARCH
- Beyond Reactive Oxygen Species
- (2009) Bradford G. Hill et al. CIRCULATION RESEARCH
- High Aldehyde Dehydrogenase Activity: A Novel Functional Marker of Murine Prostate Stem/Progenitor Cells
- (2009) Patricia E. Burger et al. STEM CELLS
- Non-P450 aldehyde oxidizing enzymes: the aldehyde dehydrogenase superfamily
- (2008) Satori A Marchitti et al. Expert Opinion on Drug Metabolism & Toxicology
- ALDH isozymes downregulation affects cell growth, cell motility and gene expression in lung cancer cells
- (2008) Jan S Moreb et al. Molecular Cancer
- Aldehyde Dehydrogenase Discriminates the CD133 Liver Cancer Stem Cell Populations
- (2008) S. Ma et al. MOLECULAR CANCER RESEARCH
- Efficient tumour formation by single human melanoma cells
- (2008) Elsa Quintana et al. NATURE
- Colorectal Cancer Stem Cells Are Enriched in Xenogeneic Tumors Following Chemotherapy
- (2008) Scott J. Dylla et al. PLoS One
- Aldehyde dehydrogenase inhibitors: α,β-Acetylenic N-substituted aminothiolesters are reversible growth inhibitors of normal epithelial but irreversible apoptogens for cancer epithelial cells from human prostate in culture
- (2007) Gerard Quash et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation